Condition: Preterm · Patent Ductus Arteriosus · Sepsis · Sponsor: St. Olavs Hospital
Non-invasive tools for monitoring of course of disease are important and necessary in the treatment of pre-term/premature infants and sick neonates. For many years, the ultrasound group in Trondheim has been at the forefront in the development of new ultrasound technology for the diagnosis and monitoring of disease. Several methods previously developed in this research group are today widely used in hospitals around the world. In this project the investigators aim to test a new ultrasound technology that allows continuous monitoring of cerebral blood flow in sick neonates and pre-term children. This technology was CE-certified in October 2022, and in this project the investigators will test the CE-certified version with the newest available approved software.
This description comes directly from the study's public registry record.
Siri Ann Nyrnes, MD, PhD · 004793062121 · siri.a.nyrnes@ntnu.no
Siv Steinsmo Ødegård, MD, PhD · 97772989 · siv.steinsmo@gmail.com
Always discuss trial participation with your own doctor first.
| Children's clinic, St. Olavs University Hospital | Trondheim, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06646250